Cat. No. | Product name | CAS No. |
DC9450 |
(R)-Baclofen
(R)-Baclofen(STX209) is a selective GABAB receptor agonist. |
69308-37-8 |
DCE-016 |
Chenodeoxycholic acid
>98%,Standard References |
474-25-9 |
DC11919 |
Arimoclomol
Featured
A nontoxic heat shock protein (HSP) coinducer and potentiator of the heat shock response. |
289893-25-0 |
DC11920 |
Arimoclomol maleate
Featured
A nontoxic, orally active heat shock protein (HSP) coinducer and potentiator of the heat shock response. |
289893-26-1 |
DC11515 |
Azeloprazole
A novel potent proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM. |
955095-45-1 |
DC11546 |
Azeloprazole sodium
A novel potent, orally active proton pump inhibitor that irreversibly inhibits H+,K+-ATPase activity with IC50 of 0.28 uM. |
955095-47-3 |
DC11519 |
Ceclazepide
A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD).. |
1801749-44-9 |
DC11688 |
Avacopan
Featured
Avacopan is a potent, selective, orally availale C5aR (CD88) inhibitor with IC50 of 0.1 nM. |
1346623-17-3 |
DC11525 |
Mocravimod
A synthetic immunosuppressant that functions as a S1P1 receptor agonist. |
509092-16-4 |
DC11512 |
Acrizanib
Featured
Acrizanib(LHA510) is a potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. |
1229453-99-9 |
DC8606 |
Alvimopan monohydrate
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
1383577-62-5 |
DC8605 |
Alvimopan dihydrate
Alvimopan(LY 246736; ADL 8-2698) is a peripherally acting mu-opioid receptor (PAM-OR, IC50= 1.7 nM) antagonist for accelerating gastrointestinal recovery after surgery. |
170098-38-1 |
DC11076 |
Ampreloxetine
Ampreloxetine (TD-9855) is a potent monoamine reuptake inhibitor with pIC50 of 8.0, 8.6 and 6.8 for human NET, SERT, and DAT, respectively. |
1227056-84-9 |
DC9034 |
Atomoxetine HCl
Atomoxetine Hcl(LY 139603; Tomoxetine Hcl) is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). |
82248-59-7 |
DC8971 |
Baclofen
Baclofen is a gamma-amino-butyric acid (GABA) derivative used as a skeletal muscle relaxant. |
1134-47-0 |
DC8895 |
benzbromaron
Featured
Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout. |
3562-84-3 |
DC11354 |
Carteolol (hydrochloride)
Carteolol is an antagonist of β-adrenergic receptors (Kd = 13 nM). |
51781-21-6 |
DC4160 |
CB-03-01
Featured
CB-03-01 is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use. |
19608-29-8 |
DC9183 |
Clomiphene citrate
Clomifene Citrate is a selective estrogen receptor modulator. |
50-41-9 |
DCAPI1091 |
Conivaptan hydrochloride
Featured
Conivaptan(YM 087) is a non-peptide inhibitor of antidiuretic hormone (vasopressin receptor antagonist) with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively. |
168626-94-6 |
DC4132 |
CP-547632
Featured
CP-547632 is as a potent inhibitor of the VEGFR-2 and basic fibroblast growth factor (FGF) kinases (IC50 11 and 9 nM, respectively). |
252003-65-9 |
DC11082 |
Danicopan (ACH-4471)
Featured
Danicopan (ACH-4471, ACH-0144471) is a highly potent, orally active Factor D inhibitor with Kd of 0.54 nM, inhibits the proteolytic activity of purified Factor D against substrate Factor B in complex with C3b, blocking production of Bb fragment IC50 of 15 nM. |
1903768-17-1 |
DC9116 |
Dantrolene sodium
Dantrolene sodium is a inhibitor of calcium channel proteins, inhibiting the release of Ca2+ from the sarcoplasm. Dantrolene sodium is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction. |
14663-23-1 |
DCAPI1107 |
Deferasirox (Exjade)
Featured
Deferasirox (Exjade) |
201530-41-8 |
DC9604 |
Desogestrel
Featured
Desogestrel(Org-2969) is a third-generation 19-nortestosterone derivative progestogen; is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP). |
54024-22-5 |
DC8485 |
E-64d(Aloxistatin)
Featured
E-64D is an inhibitor of cathepsins B and L; also thought to inhibit calpain,showed a potent activity for COVID-19(SARS-COV-2)with EC50: MERS-COV(1.275),SARS-COV(0.760) |
88321-09-9 |
DC10939 |
Edasalonexent
Edasalonexent (CAT-1004) is a bifunctional, orally administered small molecule that covalently links 2 compounds known to inhibit NF‐κB, salicylic acid and docosahexaenoic acid (DHA). |
1204317-86-1 |
DC9771 |
ACU4429,ACU 4429,ACU-4429
Featured
Emixustat hydrochloride strongly inhibits 11-cis-retinol production with IC50 values of 232 ± 3 nM. |
1141934-97-5 |
DC10314 |
Emixustat
Emixustat, a novel visual cycle modulator, is an inhibitor of the visual cycle isomerase with an IC50 value of 4.4 nM in vitro. |
1141777-14-1 |
DC11433 |
Vatiquinone
EPI-743 (Vatiquinone,EPI-589) is an orally bioavailable para-benzoquinone for treatment of inherited mitochondrial diseases, an analogue of the antioxidant ubidecarenone. |
1213269-98-7 |
DC9821 |
Ezutromid
Featured
Ezutromid is a novel Small utrophin's translation modulator with EC50 of 0.4 uM . |
945531-77-1 |
DC8912 |
Fesoterodine fumarate
Featured
Fesoterodine Fumarate is an antimuscarinic agent and is rapidly de-esterified to its active metabolite 5-hydroxymethyl tolterodine that is a muscarinic receptor antagonist. |
286930-03-8 |
DC11187 |
Fonadelpar
Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.. |
515138-06-4 |
DC11394 |
Fulacimstat(BAY 1142524)
Featured
Fulacimstat(BAY 1142524) is a small molecule chymase inhibitor. |
1488354-15-9 |
DC9859 |
GAL-021
Featured
GAL-021 is a new intravenous BKCa-channel blocker. |
1380341-99-0 |
DC9738 |
GSK2881078
Featured
GSK2881078 (GSK-2881078 ) is a selective androgen receptor modulator (SARM). |
1539314-06-1 |
DC10007 |
Ibiglustat(Genz-682452)
Featured
Ibiglustat (Genz-682452,SAR402671), is a potent and selective Glucosylceramide synthase inhibitor and ceramide glucosyltransferase inhibitor. |
1401090-53-6 |
DC7430 |
Obeticholic acid (INT-747)
Featured
INT-747(Obeticholic acid; 6-ECDCA) is a potent and selective FXR agonist(EC50=99 nM) endowed with anticholestatic activity. |
459789-99-2 |
DC7172 |
IOWH-032
iOWH032 is a novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays. |
1191252-49-9 |
DC12374 |
JNJ-10229570
Featured
JNJ-10229570 (JNJ10229570) is a novel potent, selective melanocortin receptor MC1R and MC5R antagonist with binding IC50 of 270 nM and 200 nM, respectively. |
524923-88-4 |
DC10853 |
LAU159
Featured
LAU159 is a novelα6β3γ2 GABAA receptor inhibitor. |
2055050-87-6 |
DC12386 |
Leniolisib (CDZ173)
Featured
Leniolisib (CDZ173) is a potent and selective PI3Kδ inhibitor currently in phase II/III clinical trials for the treatment of immunodeficiency disorders. |
1354690-24-6 |
DC7633 |
Ligandrol (VK5211, LGD-4033)
Featured
LGD-4033 is a novel selective androgen receptor modulator (SARM) |
1165910-22-4 |
DC9938 |
Lusutrombopag(S-888711)
Featured
Lusutrombopag(S-888711) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist being developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. |
1110766-97-6 |
DC11524 |
Mavacamten(MYK-461)
Featured
Mavacamten(MYK-461)is a small molecule that reduces contractility by decreasing the ATPase activity of the cardiac myosin heavy chain. |
1642288-47-8 |
DC9527 |
Methylnaltrexone (Bromide)
Featured
Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation. |
73232-52-7 |
DC10326 |
Mozavaptan
Mozavaptan (OPC31260) is a orally effective, nonpeptide vasopressin V2 receptor antagonist with an IC50 of 14 nM. |
137975-06-5 |
DCAPI1342 |
Nepafenac
Nepafenac |
78281-72-8 |
DC12298 |
Octreotide acetate (SMS 201-995 (acetate))
Featured
Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently. |
79517-01-4 |
DC10299 |
Olumacostat glasaretil
Olumacostat glasaretil is a small molecule inhibitor of acetyl coenzyme A carboxylase (ACC). |
1261491-89-7 |
DC11044 |
Omidenepag Isopropyl
Featured
Omidenepag Isopropyl (DE-117, OMDI) is the prodrug of Omidenepag, which is a potent, selective agonist human EP2 receptor; demonstrates excellent IOP-lowering activities following ocular administration in ocular normotensive monkeys, Omidenepag Isopropyl (OMDI) is a clinical candidate for the treatment of glaucoma. |
1187451-19-9 |
DC8353 |
PF-04418948
Featured
PF-04418948 is an orally active, potent, and selective EP2 receptor antagonist (IC50 = 16 nM). |
1078166-57-0 |
DCAPI1305 |
Pramiracetam
Pramiracetam |
68497-62-1 |
DC9162 |
Ranolazine HCl
Featured
Ranolazine(RS-43285) is an antianginal agent with antiarrhythmic properties that achieves its effects via a novel mechanism of action (inhibition of the late phase of the inward sodium current), without affecting heart rate or blood pressure (BP). |
95635-56-6 |
DC1048 |
Rapamycin (Sirolimus)
Featured
Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM. - |
53123-88-9 |
DC8185 |
Verosudil(AR-12286)
Rho-kinase (ROCK) inhibitor |
1414854-42-4 |
DC10583 |
RO 5028442
Featured
RO5028442 is a highly potent and selective Brain-Penetrant Vasopressin 1a (V1a) receptor antagonist with Kis of 1 nM (hV1a) and 39 nM (mV1a). |
920022-47-5 |
DC8198 |
RTA-408(Omaveloxolone)
Featured
RTA-408 is a synthetic triterpenoid that potently activates the antioxidative transcription factor Nrf2 and inhibits the proinflammatory transcription factor NF-κB. |
1474034-05-3 |
DC8224 |
Lifitegrast(SAR 1118)
Featured
SAR 1118 is a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist for treating dry eye. |
1025967-78-5 |
DC10925 |
SAR-100842
Featured
SAR-100842 (SAR100842) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 31 nM in β-arrestin assays. |
1195941-38-8 |
DC9600 |
Senicapoc
Featured
Senicapoc(ICA17043) is a potent and selective Gardos channel blocker; blocked Ca(2+)-induced rubidium flux from human RBCs/ inhibited RBC dehydration with IC50s of 11 nM/30 nM, respectively. IC50 value: 11/30 nM [1] Target: Gardos channel in vitro: I |
289656-45-7 |
DCAPI1485 |
Silodosin
Featured
Silodosin(Rapaflo) is an α1-adrenoceptor antagonist with high uroselectivity. Silodosin causes practically no orthostatic hypotension (in contrast to other α1 blockers). Since Silodosin is a highly selective inhibitor of the α1A adrenergic receptor, it ca |
160970-54-7 |
DC8592 |
Sivelestat (sodium salt hydrate)
Featured
Sivelestat(ONO5046; LY544349; EI546) is a competitive inhibitor of human neutrophil elastase(IC50 = 44 nM; Ki=200 nM); also inhibited leukocyte elastase obtained from rabbit, rat, hamster and mouse. |
201677-61-4 |
DC8500 |
SKQ1(Visomitin)
Featured
SKQ1 prevents amyloid-beta-induced impairment of long-term potentiation in rat hippocampal slices. |
934826-68-3 |
DC9732 |
Sufugolix(TAK-013)
Featured
Sufugolix(TAK-013) is a non-peptide, orally-active, selective antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (IC50 = 0.1 and 0.06 nM for affinity and in vitro inhibition, respectively). |
308831-61-0 |
DC11026 |
Tecovirimat
Featured
Tecovirimat (ST-246, Tpoxx) is a potent, orally bioavailable, first-in-class inhibitor of orthopoxvirus egress with EC50 of 0.01-0.6 uM against a panel of Orthopoxviruses; ST-246 is active against multiple orthopoxviruses, including vaccinia, monkeypox, c |
869572-92-9 |
DC9148 |
Tolvaptan
Featured
Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation. |
150683-30-0 |
DC11385 |
Trofinetide(NNZ2566)
Featured
Trofinetide (NNZ-2566) is an analog of a molecule which is derived from IGF-1 and occurs naturally in the brain. IGF-1 is a growth factor stimulated by growth hormone. |
853400-76-7 |
DC9816 |
Valbenazine(NBI-98854)
Featured
Valbenazine(NBI-98854) is a potent and selective VMAT2 inhibitor.. |
1025504-45-3 |
DC9187 |
Mosapride Citrate
Mosapride citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist. |
112885-42-4 |